Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Asian Journal of Psychiatry
|
October 25, 2017
Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up
M C Mauri, C Di Pace, A Reggiori, et al.
Asian Journal of Psychiatry
|
September 7, 2014
Clinical and neuropsychological correlates of major depression following post-traumatic brain injury, a prospective study
M C Mauri, S Paletta, A Colasanti, et al.
L'Encephale
|
September 1, 1995
Depressive symptoms and schizophrenia a psychopharmacological approach
M C Mauri, S Bravin, L Fabiano, et al.
Expert Opinion on Drug Safety
|
February 1, 2017
Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation
M C Mauri, A Reggiori, S Paletta, et al.
Pharmacopsychiatry
|
November 1, 1989
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine
A C Altamura, M C Mauri, F De Novellis, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1990
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels
C A Altamura, F Colacurcio, M C Mauri, et al.
Human Psychopharmacology
|
October 31, 2002
Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis
M C Mauri, L S Volonteri, A Fiorentini, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 14, 2001
Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels
M C Mauri, V Laini, L Boscati, et al.
International Journal of Psychiatry in Clinical Practice
|
June 19, 2014
Long term efficacy of paroxetine in major depression: A study with plasma levels
M C Mauri, V Laini, A Bitetto, et al.
Neuropsychobiology
|
May 23, 1998
Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment
M C Mauri, A Ferrara, L Boscati, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Asian Journal of Psychiatry
|
October 25, 2017
Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up
M C Mauri, C Di Pace, A Reggiori, et al.
Asian Journal of Psychiatry
|
September 7, 2014
Clinical and neuropsychological correlates of major depression following post-traumatic brain injury, a prospective study
M C Mauri, S Paletta, A Colasanti, et al.
L'Encephale
|
September 1, 1995
Depressive symptoms and schizophrenia a psychopharmacological approach
M C Mauri, S Bravin, L Fabiano, et al.
Expert Opinion on Drug Safety
|
February 1, 2017
Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation
M C Mauri, A Reggiori, S Paletta, et al.
Pharmacopsychiatry
|
November 1, 1989
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine
A C Altamura, M C Mauri, F De Novellis, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1990
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels
C A Altamura, F Colacurcio, M C Mauri, et al.
Human Psychopharmacology
|
October 31, 2002
Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis
M C Mauri, L S Volonteri, A Fiorentini, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 14, 2001
Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels
M C Mauri, V Laini, L Boscati, et al.
International Journal of Psychiatry in Clinical Practice
|
June 19, 2014
Long term efficacy of paroxetine in major depression: A study with plasma levels
M C Mauri, V Laini, A Bitetto, et al.
Neuropsychobiology
|
May 23, 1998
Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment
M C Mauri, A Ferrara, L Boscati, et al.
Page
of 6